Abed Agbarya

41PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersDiagnostic radiographyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Sep 26, 2026
The Impact of Angiotensin-Converting Enzyme Inhibitors on Immune-Related Adverse Events and Clinical Outcomes in Patients with Metastatic NSCLC.

|Sep 15, 2026
Correction: Shalata et al. Correlation Between Body Mass Index and Immunotherapy Response in Advanced NSCLC. Cancers 2025, 17, 1149.

|Aug 26, 2026
Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) on the Efficacy of Immunotherapy in Metastatic NSCLC.

|Jul 28, 2026
Social Network Clustering Analysis for Detection of Associated Genetic Co-Mutations in Patients with Actionable Driver Mutations in NSCLC.

|May 27, 2026
Impact of Variant Allele Frequency (VAF) Levels on Clinical Efficacy of Osimertinib in Patients with Metastatic NSCLC.

|May 27, 2026
Suction Impact on Chest Drain Duration After Lung Resection: A Study Using Digital Drainage Systems.

Pageof 7

Frequent Collaborators

22 joint publications

Walid Shalata

8 joint publications

Leonard Saiegh

6 joint publications

Dan Levy-Faber

4 joint publications

Keren Rouvinov